Journal of Genomics and Precision Medicine

Dr. Sadahiro Iwabuchi is an Associate Professor in the Department of Bioinformatics and Genomics at the Graduate School of Medical Sciences, Kanazawa University, Japan. He is a leading scientist in single-cell transcriptomics, spatial omics, cancer biology, and molecular biology, with a strong interdisciplinary background that includes neuroscience, lifestyle-related disease research, and forensic molecular science. He has over two decades of combined academic and industry experience across Japan and the United States, including postdoctoral research at the University of Iowa, Hokkaido University, and faculty roles at Wakayama Medical University. His earlier industry experience at Teijin Pharma contributed to the development of ultrasound-based bone healing devices, resulting in high-impact research with over 700 citations. Dr. Iwabuchi’s current work focuses on tumor microenvironment profiling, spatial omics integration, single-cell RNA sequencing, CRISPR-based functional genomics, and molecular pathways in cancer progression and therapy resistance. He serves as a reviewer for leading international journals and as an Editorial Board Member for Scientific Reports and Oncology Reports, contributing substantially to the advancement of modern genomics and precision medicine.

• Transcriptomics and epigenetic regulation
• Molecular pathways in chemotherapy resistance
• Multi-omics integration and computational biology

1. Associate Professor, Kanazawa University (2025–Present)

2. Lecturer/Assistant Professor at Wakayama Medical University (2017–2024)

3. Assistant Professor, Kanazawa University (2017–2020)

4. Specially Appointed Lecturer, Iwate Medical University (2016–2017)

5. Postdoctoral Researcher at the University of Iowa, USA (2011–2016)

6. Postdoctoral Researcher at Hokkaido University (2010–2011)

7. Senior Researcher at Teijin Pharma Ltd. (2002–2007)

8. Reviewer for PLOS ONE, MDPI journals, Legal Medicine

9. Editorial Board Member: Scientific Reports, Oncology Reports

10. Expertise in omics technologies, cancer models, molecular biology

11. Over 700 citations from research contributions

1. Single-cell transcriptomic profiling of tumor microenvironments

2. Spatial omics analyses in liver and pancreatic cancers

3. Molecular mechanisms of chemotherapy resistance in breast and oral cancer

4. Synaptic vesicle glutamate release mechanisms

5. Imaging and electrophysiology studies in neuronal systems

6. COVID-19 single-cell transcriptomic analyses

7. Ultrasound-based fracture healing device research (Exogen)

8. Spatial mapping of immune landscapes in tumors

9. Transcriptomic signatures of liver diseases

10. Glial-neuronal interactions in cerebral ischemic tolerance